A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks-Reference-Cited by-同舟云学术

A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks

Published:2017-03-22 Issue:3 Volume:12 Page:e0170456
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Naga Prasad Sathyamangla V.,Gupta Manveen K.,Duan Zhong-Hui,Surampudi Venkata Suresh K.,Liu Chang-Gong,Kotwal Ashwin,Moravec Christine S.,Starling Randall C.,Perez Dianne M.,Sen Subha,Wu Qingyu,Plow Edward F.,Karnik Sadashiva

Funder

Cleveland Clnic Start up funds

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Controversies in ventricular remodelling;LH Opie;Lancet,2006

2. MicroRNAs: genomics, biogenesis, mechanism, and function;DP Bartel;Cell,2004

3. MicroRNAs and endocrine biology;TL Cuellar;J Endocrinol,2005

4. Dicing and slicing: the core machinery of the RNA interference pathway;SM Hammond;FEBS Lett,2005

5. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure;E van Rooij;Proc Natl Acad Sci U S A,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoadiponectinemia-induced upregulation of microRNA449b downregulating Nrf-1 aggravates cardiac ischemia-reperfusion injury in diabetic mice;Journal of Molecular and Cellular Cardiology;2023-09

2. Mitochondrial miRNA as epigenomic signatures: Visualizing aging-associated heart diseases through a new lens;Ageing Research Reviews;2023-04

3. Glucagon-Like Peptide-1 Receptor Agonist Protects Against Diabetic Cardiomyopathy by Modulating microRNA-29b-3p/SLMAP;Drug Design, Development and Therapy;2023-03

4. A Systematic Review of miRNA and cfDNA as Potential Biomarkers for Liquid Biopsy in Myocarditis and Inflammatory Dilated Cardiomyopathy;Biomolecules;2022-10-13

5. Dissecting miRNA–Gene Networks to Map Clinical Utility Roads of Pharmacogenomics-Guided Therapeutic Decisions in Cardiovascular Precision Medicine;Cells;2022-02-10